The effects of melatonin on signaling pathways and molecules involved in glioma
- 20 January 2020
- journal article
- editorial
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 34 (2) , 189-191
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cellsBMC Neuroscience, 2019
- The effects of melatonin on signaling pathways and molecules involved in gliomaFundamental & Clinical Pharmacology, 2019
- Targeting Glioblastoma Stem Cells through Disruption of the Circadian ClockCancer Discovery, 2019
- Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic ModificationsInternational Journal of Molecular Sciences, 2019
- Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of GlioblastomaPharmaceutical Research, 2019
- Glioblastoma: Role of Mitochondria N-acetylserotonin/Melatonin Ratio in Mediating Effects of miR-451 and Aryl Hydrocarbon Receptor and in Coordinating Wider Biochemical ChangesInternational Journal of Tryptophan Research, 2019
- Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling AxisInternational Journal of Biological Sciences, 2017
- Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical ChangesCurrent Pharmaceutical Design, 2016
- Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1Proceedings of the National Academy of Sciences, 2015
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and miceNeuro-Oncology, 2010